PD Dr. Benno Weigmann

Medizinische Fakultät

Reply to "Tolerogenic insulin peptide therapy precipitates type 1 diabetes" (2017) Daniel C, Weigmann B, Von Boehmer H Journal article, Letter Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice (2017) Popp V, Gerlach K, Mott S, Turowska A, Garn H, Atreya R, Lehr HA, et al. Journal article Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis (2017) Reissig S, Tang Y, Nikolaev A, Gerlach K, Wolf C, Davari K, Gallus C, et al. Journal article Th9 cells in inflammatory bowel diseases (2017) Weigmann B, Neurath M Journal article Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease (2017) Chiriac MT, Buchen B, Wandersee A, Hundorfean G, Günther C, Bourjau Y, Doyle SE, et al. Journal article Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells (2017) Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Lin NY, et al. Journal article Epicutaneous and Oral Low-Zone Tolerance Protects from Colitis in Mice (2016) Schmidt T, Lorenz N, Raker V, Reissig S, Waisman A, Weigmann B, Steinbrink K Journal article Oxazolone-Induced Colitis as a Model of Th2 Immune Responses in the Intestinal Mucosa (2016) Weigmann B, Neurath M Journal article miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity (2016) Serr I, Fuerst RW, Ott VB, Scherm MG, Nikolaev A, Goekmen F, Kaelin S, et al. Journal article Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa-Pharmaceutical Characterization and Fluorescence Imaging (2016) Ali H, Weigmann B, Collnot EM, Khan SA, Windbergs M, Lehr CM Journal article